Medindia  » 
Health Press Releases A-Z
  View original content:https://www.prnewswire.com/news-releases/nature-publishes-discovery-and-preclinical-results-for-abbv-cls-484-a-potential-first-in-class-ptpn2n1-inhibitor-in-cancer-immunotherapy-301947240.html	SOURCE  AbbVie  Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024 
